Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient care.
It focuses on the needs of cardiologists and primary care clinicians, but is also applicable to providers
at all levels. is Guideline should not be considered exclusive of other methods of care reasonably
directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of
conduct must be made by the clinician aer consideration of each individual patient situation.
Neither IGC, the medical associations, nor the authors endorse any product or service associated with
the distributor of this clinical reference tool.
ACCHF17061b
106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
Copyright © 2017 All rights reserved
Source
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos
GS, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE,
Peterson PN, Stevenson LW, Westlake C. 2017 ACC/AHA/HFSA focused update of the
2013 ACCF/AHA guideline for the management of heart failure: a report of the American
College of Cardiolog y/American Heart Association Task Force on Clinical Practice Guidelines
and the Heart Failure Society of America. Circulation. 2017;000:e000–e000. DOI: 10.1161/
CIR.0000000000000509.
To access the digital or mobile version of this guideline for free,
or to view the full text guideline, visit
GuidelineCentral.com/HFupdate
Novartis Pharmaceuticals Corporation
East Hanover, New Jersey 07936-1080 ©2017 Novartis Printed in the USA 6/17 HFS-1346038
The printing and distribution of this educational resource
was supported by Novartis Pharmaceuticals Corporation.
6/17 HFS-1344395
